Abstract

Apolipoprotein C‐III (apoC‐III) is not only predominantly synthesized by the liver but also by the small intestine. Because apoC‐III is secreted from the intestine on the chylomicron along with lipid absorption, we questioned whether apoC‐III might play a role in intestinal lipid absorption and/or transport. Using both wild‐type (WT) and apoC‐III transgenic (apoC‐III Tg) mice, we showed that apoC‐III Tg mice have decreased lymphatic lipid transport compared with WT mice in response to an intraduodenal infusion of radiolabeled lipid. This is associated with accumulation of radiolabeled lipids in the luminal compartment of the apoC‐III Tg mice, indicating delayed lipid uptake from the lumen. The total amount of radioactive lipids in the mucosal compartment did not differ between apoC‐III Tg and WT mice, but the lipid distribution analysis indicated a predominance of free fatty acids and monoacylglycerol in the mucosa of apoC‐III Tg mice, implying impaired esterification capacity. Thus, the mechanisms underlying the reduced lymphatic lipid transport in apoC‐III Tg mice involve both a delayed lipid uptake into enterocytes, as well as impaired esterification to form triglyceride in the mucosa. These data document a novel role for apoC‐III in the uptake, re‐esterification, and lymphatic transport of dietary lipids in the intestine.

Highlights

  • Apolipoprotein C-III is an exchangeable lipoprotein produced by both the liver and the intestine (Wu and Windmueller 1978; Haddad et al 1986; Lenich et al 1988)

  • Expression apoC-III mRNA is highest in the proximal intestine, which coincides with the site of highest lipid absorption (Booth et al 1961)

  • Several genetically modified mouse models have been used to study the effect of apoC-III on lipid metabolism in the circulation, and a detailed mechanism by which apoC-III blocks hydrolysis and clearance of triacylglycerol-rich lipoproteins (TRLs) has been reported (Aalto-Set€al€a et al 1996; Mann et al 1997; Altomonte et al 2004; Cohn et al 2004b; Gerritsen et al 2005)

Read more

Summary

Introduction

Apolipoprotein C-III (apoC-III) is an exchangeable lipoprotein produced by both the liver and the intestine (Wu and Windmueller 1978; Haddad et al 1986; Lenich et al 1988). Overproduction of apoC-III and of triacylglycerol-rich lipoproteins (TRLs) containing apoCIII is a common feature in patients with hypertriglyceridemia (Fredenrich et al 1997; Cohn et al 2004a; Zheng et al 2010). This relationship between apoC-III and disease is related to its regulation of the clearance and metabolism of TRLs. In plasma, apoC-III resides on very low-density lipoproteins (VLDL) and chylomicrons, as well as highdensity lipoproteins (HDL) (Brown et al 1969; Schonfeld et al 1979; Fredenrich et al 1997; Ginsberg and Brown 2011).

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call